基本信息
views: 262
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Research areas comprise cost-effectiveness methods, for example, in vaccinology, transfusion science, prevention of (complications) of chronic diseases, orphan drugs and personalized medicine, inclusive gene therapies. He serves (served) on various committees advising the Dutch government on reimbursement of drugs and vaccines (CVZ/ZiNL and Health Council). Also, he is advisor to various health-economics consultancy companies and pharmaceutical companies worldwide, Ministries of Health in neighbouring countries, member of editorial boards of various scientific journals (for example, Value in Health, Frontiers in Pharmacology, Vaccines and PLoS One), on advisory boards for pharmaceutical companies, expert consultant for WHO and member of WHO’s SAGE-committees. He is a member of UK’s Joint Committee of Vaccination & Immunization and advisor to the All Wales Medicines Strategy Group (Grwp Strategaeth Meddyginiaethau Gymru Gyfam). He is specialized in the role of pharmacoeconomics/health economics in the reimbursement process. He has approximately 500 MEDLINE-publications, an H-factor of 60 and extensive teaching/lecturing experience (Groningen, Amsterdam, Utrecht, Heidelberg, Bielefeld, Ankara, Sofia, various universities in Indonesia, JoBurg, Moscow and Hanoi). So far, he attracted 10 EU-projects, 10 WHO-projects, various national projects from the National Institute of Public Health and the MoH, projects from NGOs and multiple projects from pharma, aggregating to over 15 million EUR in the last decade. His research often features in newspapers and Dutch television. He is involved in 5 spin-off consultancy companies from the University in various roles.
Research Interests
Papers共 1025 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Techniques in Coloproctologyno. 1 (2024): 1-20
INFECTIOUS DISEASES AND THERAPYno. 3 (2024): 481-499
European Journal of Surgical Oncologyno. 2 (2024): 107717
Lisa A. de Jong, Xinyu Li,Sajad Emamipour, Sjoukje van der Werf,Maarten J. Postma,Peter R. van Dijk,Talitha L. Feenstra
PharmacoEconomicspp.1-25, (2024)
PharmacoEconomics - Openno. 4 (2024): 1-14
Romy Deviandri,Hugo C van der Veen, Abdul Khairul R Purba, Ajeng V Icanervilia, Andri Mt Lubis,Inge van den Akker-Scheek,Maarten J Postma
BMC health services researchno. 1 (2024): 784-784
Blessing Dzingirai,Leolin Katsidzira, Vongai Mwanesani,Maarten Jacobus Postma, Marinus van Hulst,Nyashadzaishe Mafirakureva
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCHno. 5 (2024): 687-695
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCHno. 2 (2024): 251-265
Expert review of vaccinesno. 1 (2024): 655-673
Value in Health Regional Issues (2024): 32-40
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn